http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-3453152-B2

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
filingDate 1992-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2003-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2003-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-3453152-B2
titleOfInvention Anti-inflammatory eye drops
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8318739-B2
priorityDate 1992-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426662881
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448928697
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450183611
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5359386
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10116
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23669592
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453691066
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450434480
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23680220
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24682
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13849045
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419566278
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546958
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23702350
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449021452
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23663963
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20849128
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10116

Total number of triples: 31.